Travere Therapeutics is a San Diego biopharmaceutical company that develops and sells treatments for rare kidney and metabolic diseases. It last closed at $47.00 on Nov 20, down 2.69% on the day. The next earnings report for TVTX is expected around Mon, Jan 11, 2027, after the close. For the quarter ended Sep 2026, TVTX reported EPS of -$0.55 on revenue of $224.6M, with revenue up 36.2% from a year ago. Over its last 8 reports the stock moved an average of 7.3% the session after earnings. Over the last 12 months TVTX insiders bought $0 of stock on the open market and sold $110.4M, according to SEC Form 4 filings.
AI Auto Pilots
Is TVTX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold TVTX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on TVTXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
TVTX · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold
The stock is 7% below its 20 day and 15% below its 50 day average. It is 2% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 35), near oversold. The nearest support is the Pivot S1 at $46.15, and the nearest resistance the Pivot at $47.75.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 5.2%/day
Key levels
$68.7352 week high+46.2%
$57.60100 day average+22.6%
$54.2350 day average+15.4%
$50.3220 day average+7.1%
$48.60Pivot R1+3.4%
$48.58Swing high (May 29)+3.4%
$48.13200 day average+2.4%
$47.75Pivot+1.6%
$47.00Last close
$46.15Pivot S1−1.8%
$44.73Swing low (Nov 3)−4.8%
$22.5952 week low−51.9%
Indicators
RSI (14)
35.19
Weak, oversold below 30
Neutral
MACD
-1.31
Below its signal line
Bearish
Stochastic
44.1
Middle of its range
Neutral
ADX (14)
17.8
No clear trend
Williams %R
-73.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
-217.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−5.2%
Change over 10 sessions
Bearish
ATR (14)
$2.46
Typical daily range, 5.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 11.1%/day
Key levels
$68.7352 week high+46.2%
$57.60100 day average+22.6%
$54.2350 day average+15.4%
$50.3220 day average+7.1%
$48.60Pivot R1+3.4%
$48.58Swing high (May 29)+3.4%
$48.13200 day average+2.4%
$47.75Pivot+1.6%
$47.00Last close
$46.15Pivot S1−1.8%
$44.73Swing low (Nov 3)−4.8%
$22.5952 week low−51.9%
Indicators
RSI (14)
40.68
Middle of its range
Neutral
MACD
0.62
Below its signal line
Bearish
Stochastic
18.1
Near the bottom of its range
Oversold
ADX (14)
34.1
Trending down
Williams %R
-90.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-121.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−29.0%
Change over 10 sessions
Bearish
ATR (14)
$5.23
Typical daily range, 11.1% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for TVTX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how TVTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow TVTX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for TVTXHow many large options trades hit TVTX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in TVTX in the last 90 days.
From SEC Form 4 filings by TVTX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TVTX is in one of them and how their past TVTX trades turned out.
Travere Therapeutics is a biopharmaceutical company based in San Diego, California. It develops and sells treatments for people with rare kidney and metabolic diseases. Its approved product, FILSPARI, is indicated to slow kidney function decline in adults with a rare kidney disease called primary IgAN. The company is also seeking approval of FILSPARI for another kidney condition, FSGS, and is developing pegtibatinase for HCU, a genetic metabolic disorder.